Parallels and distinctions between T and NKT cell development in the thymus

Immunology and Cell Biology

Volumn 82, Issue 3, 2004, Pages 269-275

  Berzins, Stuart P ^a   Uldrich, Adam P ^a,c   Pellicci, Daniel G ^a   Mcnab, Finlay ^a   Hayakawa, Yoshihiro ^b   Smyth, Mark J ^b   Godfrey, Dale I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

CD1d; Development; NK1.1; NKT cells; Thymus

Indexed keywords

ANTIGEN EXPRESSION; AUTOIMMUNITY; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; LIGAND BINDING; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; REVIEW; T LYMPHOCYTE; THYMUS;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL DIFFERENTIATION; HUMANS; KILLER CELLS, NATURAL; MICE; T-LYMPHOCYTES; THYMUS GLAND;

EID: 3042847448     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0818-9641.2004.01256.x     Document Type: Review

References (58)

1. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol. Today 2000; 21: 573-83.
2. Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 2003; 3: 211-22.
3. Smyth MJ et al. NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 2002; 14: 165-71.
4. Kronenberg M, Gapin L. The unconventional lifestyle of NKT Cells. Nat. Rev. Immunol. 2002; 2: 557-68.
5. Hammond KJL et al. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 1999; 29: 3768-81.
6. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev. Immunol. 2004; 4: 231-7.
7. Sykes M. Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+CD4-CD8- and alpha beta TCR+NK1.1+cells. J. Immunol. 1990; 145: 3209-15.
8. Zlotnik A, Godfrey DI, Fischer M, Suda T. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. J. Immunol. 1992; 149: 1211-5.
9. Arase H, Arase N, Nakagawa K, Good RA, Onoe K. NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur. J. Immunol. 1993; 23: 307-10.
10. Bendelac A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 1995; 182: 2091-6.
11. Lantz O, Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 1994; 180: 1097-106.
12. Skold M, Cardell S. Differential regulation of Ly49 expression on CD4(+) and CD4(-) CD8(-) (double negative) NK1.1(+) T cells. Eur. J. Immunol. 2000; 30: 2488-96.
13. Brigl M, Brenner MD. CD1: Antigen presentation and T cell function. Ann. Rev. Immunol. 2004; 22: 817-90.
14. Kawano T et al. Cd1d-Restricted and Tcr-Mediated Activation of V (Alpha) 14 Nkt Cells by Glycosylceramides. Science. 1997; 278: 1626-9.
15. Matsuda JL et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000; 192: 741-53.
16. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 2000; 191: 1895-903.
17. Taniguchi M, Nakayama T. Recognition and function of V alpha 14 NKT cells. Semin. Immunol. 2000; 12: 543-50.
18. Coles MC, Raulet DH. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J. Immunol. 2000; 164: 2412-8.
19. Pellicci DG et al. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-) CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 2002; 195: 835-44.
20. Hammond K, Cain W, Vandriel I, Godfrey D. Three day neonatal thymectomy selectively depletes Nk1.1+ T cells. Int. Immunol. 1998; 10: 1491-9.
21. Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature. 1999; 402: 255-62.
22. MacDonald HR. Development and selection of NKT cells. Curr. Opin. Immunol. 2002; 14: 250-4.
23. Eberl G, Fehling HJ, von Boehmer H, MacDonald HR. Absolute requirement for the pre-T cell receptor alpha chain during NK1.1(+) TCR alpha beta cell development. Eur. J. Immunol. 999; 29: 1966-71.
24. Shimamura M, Ohteki T, Beutner U, MacDonald HR. Lack of directed V alpha 14-J alpha 281 rearrangements in NK1+ T cells. Eur. J. Immunol. 1997 27: 1576-9.
25. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu. Rev. Immunol. 2003; 21: 139-76.
26. Gapin L, Matsuda JL, Surh CD, Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CDId. Nature Immunol. 2001; 2: 971-8.
27. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A. A thymic precursor to the NK T cell lineage. Science. 2002; 296: 553-5.
28. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997; 15: 535-62.
29. Xu H, Chun T, Colmone A, Nguyen H, Wang CR. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells. J. Immunol. 2003; 171: 4105-12.
30. Forestier C et al. T cell development in mice expressing CD1d directed by a classical MHC class II promoter. J. Immunol. 2003; 171: 4096-104.
31. Honey K et al. Thymocyte expression of cathepsin L is essential for NKT cell development. Nature Immunol. 2002; 3: 1069-74.
32. Chiu YH et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 1999; 189: 103-10.
33. Elewaut D et al. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells. J. Exp. Med. 2003; 198: 1133-46.
34. Riese RJ et al. Regulation of CD1 function and NK1.1 (+) T cell selection and maturation by cathepsin S. Immunity. 2001; 15: 909-19.
35. Ohashi PS. Negative selection and autoimmunity. Curr. Opin. Immunol. 2003; 15: 668-76.
36. Chun T et al. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J. Exp. Med. 2003; 197: 907-18.
37. Pellicci DG et al. Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide. Eur. J. Immunol. 2003; 33: 1816-23.
38. Stanic AK et al. NF-kappaB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J. Immunol. 2004; 172: 2265-73.
39. Sprent J, Kishimoto H. The thymus and negative selection. Immunol. Rev. 2002; 185: 126-35.
40. Yang Y et al. Control of NKT cell differentiation by tissue-specific microenvironments. J. Immunol. 2003; 171: 5913-20.
41. Hammond KJL et al. CD1d-restricted NKT cells: An interstrain comparison. J. Immunol. 2001; 167: 1164-73.
42. Bendelac A, Killeen N, Littman DR, Schwartz RH. A subset of CD4+ thymocytes selected by MHC class I molecules. Science. 1994; 263: 1774-8.
43. Eberl G, Lowin-Kropf B, MacDonald HR. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 1999; 163: 4091-4.
44. Gadue P, Stein PL. NK T cell precursors exhibit differential cytokine regulation and require it for efficient maturation. J. Immunol. 2002; 169: 2397-406.
45. Maeda M, Lohwasser S, Yamamura T, Takei F. Regulation of NKT cells by Ly49: Analysis of primary NKT cells and generation of NKT cell line. J. Immunol. 2001; 167: 4180-6.
46. McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 2002; 14: 615-21.
47. Middleton D, Curran M, Maxwell L. Natural killer cells and their receptors. Transpl. Immunol. 2002; 10: 147-64.
48. Gabor MJ, Godfrey DI, Scollay R. Recent thymic emigrants are distinct from most medullary thymocytes. Eur. J. Immunol. 1997; 27: 2010-5.
49. Hammond KJL et al. Alpha/Beta-T cell receptor (Tcr)(+)Cd4 (-)Cd8(-)(Nkt) thymocytes Prevent insulin-dependent diabetes mellitus in nonobese diabetic (Nod)/Lt mice by the influence of interleukin (II)-4 and/or II-10. J. Exp. Med. 1998; 187: 1047-56.
50. Voll RE et al. NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity. 2000; 13: 677-89.
51. Sivakumar V, Hammond KJ, Howells N, Pfeffer K, Weih F. Differential requirement for Rel/nuclear factor (kappa) B family members in natural killer T cell development. J. Exp. Med. 2003; 197: 1613-21.
52. Elewaut D et al. NIK-dependent ReIB activation defines a unique signaling pathway for the development of V(α)14i NKT cells. J. Exp. Med. 2003; 197: 1623-33.
53. Matsuda JL et al. Homeostasis V (alpha) 14i NKT cells. Nature Immunol. 2002; 3: 966-74.
54. Ohteki T, Ho S, Suzuki H, Mak TW, Ohashi PS. Role for IL-15/ IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. J. Immunol. 1997; 159: 5931-5.
55. Williams KL et al. BATF transgenic mice reveal a role for activator protein-1 in NKT cell development. J. Immunol. 2003; 170: 2417-26.
56. Walunas TL, Wang B, Wang CR, Leiden JM. Cutting edge: The Ets1 transcription factor is required for the development of NK T cells in mice. J. Immunol. 2000; 164: 2857-60.
57. Elewaut D et al. Membrane lymphotoxin is required for the development of different subpopulations of NK T cells. J. Immunol. 2000; 165: 671-9.
58. Iizuka K et al. Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl Acad. Sci. USA 1999; 96: 6336-40.